机构:[1]Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.四川大学华西医院[2]State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, China.[3]Precision Research Center for Refractory Diseases, Institute for Clinical Research, Shanghai General Hospital, Shanghai Jiao Tong University of Medicine, Shanghai, China.
Key Project of the Science
and Technology Department of Sichuan Province (NO.
2022YFH0100), the National Natural Science Foundation of
China (NO. 82171829), the 1·3·5 Project for Disciplines of
Excellence, West China Hospital, Sichuan University (NO.
ZYYC21012), and the Fundamental Research Funds for the
Central Universities (20822041E4084).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2022]版:
大类|2 区医学
小类|2 区免疫学
最新[2023]版:
大类|2 区医学
小类|2 区免疫学
第一作者:
第一作者机构:[1]Department of Biotherapy, State Key Laboratory of Biotherapy and Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
通讯作者:
推荐引用方式(GB/T 7714):
Gui Yuanyuan,Cheng Hao,Zhou Jingyang,et al.Development and function of natural TCR+ CD8aa+ intraepithelial lymphocytes[J].Frontiers in immunology.2022,13:1059042.doi:10.3389/fimmu.2022.1059042.
APA:
Gui Yuanyuan,Cheng Hao,Zhou Jingyang,Xu Hao,Han Jiajia&Zhang Dunfang.(2022).Development and function of natural TCR+ CD8aa+ intraepithelial lymphocytes.Frontiers in immunology,13,
MLA:
Gui Yuanyuan,et al."Development and function of natural TCR+ CD8aa+ intraepithelial lymphocytes".Frontiers in immunology 13.(2022):1059042